Form 4 for AMGN Amgen
Accepted 2022-05-04 00:00:00 ET · period of report 2022-05-02 · accession 0001127602-22-013339 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-04 | 2022-05-03 | AMGN | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $230.92 | -2,692 | 621.9K | -0.4% | -$621.6K |
| D | 2022-05-04 | 2022-05-02 | AMGN | Bradway Robert A | COB, CEO, Pres, Dir | A - Grant | $0.00 | +13.8K | 624.5K | +2% | $0 |
| D | 2022-05-04 | 2022-05-02 | AMGN | Bradway Robert A | COB, CEO, Pres, Dir | A - Grant | $0.00 | +112.5K | 112.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-03 | F | D | 2,692 | $230.92 | 621,858 | D | — | — | (F3) These shares include 1,688 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. (F2) These shares include the following RSUs granted under the Company's equity plans: 5,369 RSUs which will vest in an installment of 5,369 on 5/3/2023; 12,184 RSUs which vest in installments of 4,020 on 5/05/2022, 4,021 on 5/5/2023 and 4,143 on 5/5/2024; 13,280 RSUs which vest in two installments of 4,382 on 4/30/2023 and 4/30/2024 and one installment of 4,516 on 4/30/2025; and 13,781 RSUs which will vest in installments of 4,547 on 5/2/2024, 4,548 on 5/2/2025, and 4,686 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. |
| 2 | Common | Common Stock | 2022-05-02 | A | A | 13,781 | $0.00 | 624,550 | D | — | — | (F1) The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/2/2024, 5/2/2025 and 5/2/2026, respectively. |
| 3 | Derivative | Nqso (Right to Buy) | 2022-05-02 | A | A | 112,508 | $0.00 | 112,508 | D | $230.92 · 2024-05-02 to 2032-05-02 | 112,508 Common Stock | (F4) These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/2/2024, 5/2/2025 and 5/2/2026, respectively |